Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of Advanced Non-Small Cell Lung Cancer in 2018.

× No keyword cloud information.

38 in total

Review 1. Challenges and unanswered questions for the next decade of immune-oncology research in NSCLC.

Authors: Niki Karachaliou; Manuel Fernandez-Bruno; Jillian Wilhelmina Paulina Bracht; Rafael Rosell
Journal: Transl Lung Cancer Res Date: 2018-12

2. Strategies for first-line immunotherapy in squamous cell lung cancer: are combinations a game changer?

Authors: Niki Karachaliou; Manuel Fernandez-Bruno; Rafael Rosell
Journal: Transl Lung Cancer Res Date: 2018-09

3. Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China.

Authors: Xiangyu Zhang; Liang Zeng; Yizhi Li; Qinqin Xu; Haiyan Yang; Analyn Lizaso; Xinru Mao; Ren'an Jin; Yu Zeng; Qinglin Li; Jianbo Wang; Yang Li; Yongchang Zhang; Nong Yang
Journal: Cancer Immunol Immunother Date: 2021-02-10 Impact factor: 6.968

Review 4. Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells.

Authors: Ugo Testa; Germana Castelli; Elvira Pelosi
Journal: Cancers (Basel) Date: 2018-07-27 Impact factor: 6.639

Review 5. Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes.

Authors: Deborah B Doroshow; Miguel F Sanmamed; Katherine Hastings; Katerina Politi; David L Rimm; Lieping Chen; Ignacio Melero; Kurt A Schalper; Roy S Herbst
Journal: Clin Cancer Res Date: 2019-03-01 Impact factor: 12.531

6. Patient-Centered Approach to Benefit-Risk Characterization Using Number Needed to Benefit and Number Needed to Harm: Advanced Non-Small-Cell Lung Cancer.

Authors: Gokaraju K Raju; Sean Khozin; Karthik Gurumurthi; Reuben Domike; Janet Woodcock
Journal: JCO Clin Cancer Inform Date: 2020-08

Treatment of Advanced Non-Small Cell Lung Cancer in 2018.

Review 1. Challenges and unanswered questions for the next decade of immune-oncology research in NSCLC.

2. Strategies for first-line immunotherapy in squamous cell lung cancer: are combinations a game changer?

3. Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China.

Review 4. Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells.

Review 5. Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes.

6. Patient-Centered Approach to Benefit-Risk Characterization Using Number Needed to Benefit and Number Needed to Harm: Advanced Non-Small-Cell Lung Cancer.

Review 7. Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy.

8. Current perspective on the diagnosis of malignant pleural effusion.

Review 9. Cardiovascular Complications Associated with Contemporary Lung Cancer Treatments.

Review 10. Acetylcholine signaling system in progression of lung cancers.